NCT02722668 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02722668
Title	UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Masonic Cancer Center, University of Minnesota
Indications	aggressive NK-cell leukemia lymphoplasmacytic lymphoma chronic myeloid leukemia Burkitt lymphoma multiple myeloma bone marrow cancer follicular lymphoma mantle cell lymphoma acute leukemia marginal zone lymphoma myelodysplastic syndrome Hodgkin's lymphoma anaplastic large cell lymphoma myeloproliferative neoplasm chronic lymphocytic leukemia/small lymphocytic lymphoma prolymphocytic leukemia
Therapies	Cyclophosphamide + Fludarabine + Mycophenolate mofetil Sirolimus anti-thymocyte globulin
Age Groups:	adult \| child \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Masonic Cancer Center at University of Minnesota		Minneapolis	Minnesota	55455	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02722668Clinical Trial Detail